Chicago, Feb. 17 – Amgen Inc. sold $4 billion of notes in four parts on Thursday with maturities spanning a time frame from 2029 to 2062 (Baa1/A-/BBB+), according to an FWP filed with the Securities and Exchange Commission.
The four tranches are the following:
• $750 million of 3% senior notes due 2029 priced at 99.687 to yield 3.05%, or at a spread of Treasuries plus 110 basis points;
• $1 billion of 3.35% senior notes due 2032 priced at 99.756 to yield 3.379%, or with a spread of Treasuries plus 140 bps;
• $1 billion of 4.2% senior notes due 2052 priced at 99.442 to yield 4.233%, or with a spread of Treasuries plus 190 bps; and
• $1.25 billion of 4.4% senior notes due 2026 priced at 99.384 to yield 4.433%, or at a spread of Treasuries plus 210 bps.
The notes feature a make-whole call until two months prior to maturity for the 2029 notes, three months prior to maturity for the 2032 notes, six months prior to maturity for the 2052 notes and six months prior to maturity for the 2062 notes and par calls after those dates.
BofA Securities Inc., Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC are the bookrunners.
Barclays, BNP Paribas Securities Corp., Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC are also joint bookrunners.
Proceeds from the 2029 green notes will be used for eligible projects.
Proceeds from the remaining notes will be used for general corporate purposes, including repurchasing upcoming debt maturities.
Amgen is a Thousand Oaks, Calif., manufacturer and marketer of human therapeutics based upon advances in cellular and molecular biology.
| Issuer: | Amgen Inc.
|
| Issue: | Senior notes
|
| Amount: | $4 billion
|
| Bookrunners: | BofA Securities Inc., Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Barclays, BNP Paribas Securities Corp., Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC
|
| Co-managers: | Deutsche Bank Securities Inc., HSBC Securities (USA) Inc., Mizuho Securities USA LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, SMBC Nikko Securities America, Inc., Wells Fargo Securities, LLC, Academy Securities, Inc., R. Seelaus & Co., LLC, Samuel A. Ramirez & Co., Inc. and Siebert Williams Shank & Co., LLC
|
| Counsel to issuer: | Latham & Watkins LLP
|
| Counsel to bookrunners: | Shearman & Sterling LLP
|
| Trustee: | Bank of New York Mellon Trust Co., NA
|
| Trade date: | Feb. 17
|
| Settlement date: | Feb. 22
|
| Ratings: | Moody’s: Baa1
|
| S&P: A-
|
| Fitch: BBB+
|
| Distribution: | SEC registered
|
|
|
| 2029 notes
|
| Issue: | Green notes
|
| Amount: | $750 million
|
| Maturity: | Feb. 22, 2029
|
| Coupon: | 3%
|
| Price: | 99.687
|
| Yield: | 3.05%
|
| Spread: | Treasuries plus 110 bps
|
| Call features: | Make-whole call at Treasuries plus 20 bps; par call starting Dec. 22, 2028
|
| Cusip: | 031162DD9
|
|
|
| 2032 notes
|
| Amount: | $1 billion
|
| Maturity: | Feb. 22, 2032
|
| Coupon: | 3.35%
|
| Price: | 99.756
|
| Yield: | 3.379%
|
| Spread: | Treasuries plus 140 bps
|
| Call features: | Make-whole call at Treasuries plus 25 bps; par call starting Nov. 22, 2031
|
| Cusip: | 031162DE7
|
|
|
| 2052 notes
|
| Amount: | $1 billion
|
| Maturity: | Feb. 22, 2052
|
| Coupon: | 4.2%
|
| Price: | 99.442
|
| Yield: | 4.233%
|
| Spread: | Treasuries plus 190 bps
|
| Call features: | Make-whole call at Treasuries plus 30 bps; par call starting Aug. 22, 2051
|
| Cusip: | 031162DF4
|
|
|
| 2062 notes
|
| Amount: | $1.25 billion
|
| Maturity: | Feb. 22, 2062
|
| Coupon: | 4.4%
|
| Price: | 99.384
|
| Yield: | 4.433%
|
| Spread: | Treasuries plus 210 bps
|
| Call features: | Make-whole call at Treasuries plus 35 bps; par call starting Aug. 22, 2061
|
| Cusip: | 031162DG2
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
